Kumar Singh Saikatendu
Takeda (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Computational Drug Discovery Methods, Protein Structure and Dynamics, PARP inhibition in cancer therapy, COVID-19 Clinical Research Studies
Most-Cited Works
- → Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme(2006)432 cited
- → Structural Basis of Severe Acute Respiratory Syndrome Coronavirus ADP-Ribose-1″-Phosphate Dephosphorylation by a Conserved Domain of nsP3(2005)218 cited
- → Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3(2008)193 cited
- → Accelerating antiviral drug discovery: lessons from COVID-19(2023)174 cited
- → Progress towards a public chemogenomic set for protein kinases and a call for contributions(2017)168 cited
- → Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein(2007)151 cited
- → TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma(2018)138 cited
- → Crystal Structure of Nonstructural Protein 10 from the Severe Acute Respiratory Syndrome Coronavirus Reveals a Novel Fold with Two Zinc-Binding Motifs(2006)125 cited
- → Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H -pyrazolo[3,4- c ]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships(2018)115 cited
- → The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification(2021)110 cited